Malik Y. Kahook - 05 Feb 2026 Form 3 Insider Report for SpyGlass Pharma, Inc. (SGP)

Role: President, Chief Medical Officer, Executive Chair Exhibit 24 - Power of Attorney, Director
Signature: /s/ Brian Aukshunas. as Attorney-in-Fact
Issuer symbol: SGP
Transactions as of: 05 Feb 2026
Net transactions value: $0
Form type: 3
Filing time: 05 Feb 2026, 13:01:38 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Kahook Malik Y.	President, Chief Medical Officer, Executive Chair Exhibit 24 - Power of Attorney, Director	C/O SPYGLASS PHARMA, INC., 27061 ALISO CREEK RD., SUITE 100, ALISO VIEJO	/s/ Brian Aukshunas. as Attorney-in-Fact	05 Feb 2026	0002106409

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	SGP	Common Stock						873,978	05 Feb 2026	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	SGP	Stock Option (right to buy)							05 Feb 2026	Common Stock	72,389	$2.18	Direct	F1
holding	SGP	Stock Option (right to buy)							05 Feb 2026	Common Stock	191,874	$2.87	Direct	F2
holding	SGP	Stock Option (right to buy)							05 Feb 2026	Common Stock	170,475	$7.11	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean October 6, 2023.
F2	Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 20, 2025.
F3	Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean May 30, 2025.

Remarks:

President, Chief Medical Officer, Executive Chair Exhibit 24 - Power of Attorney